


















































to	 oxygen.	 Although	 ROS	 are	 necessary	 for	 certain	 cell	 signaling	 pathways,	 they	 are	
generally	 thought	 to	 be	 damaging	 to	 the	 cell.	 Cells	 can	 protect	 themselves	 against	
oxidative	damage	using	antioxidant	enzymes	that	break	down	superoxide	and	other	ROS.	
Antioxidants	 are	 currently	 used	 as	 therapeutics	 for	 a	 number	 of	 diseases,	 but	 so	 far,	
mitochondria	targeted	antioxidants	have	not	been	well	characterized	for	this	purpose.	
Manganese	 superoxide	 dismutase	 (SOD2)	 is	 an	 antioxidant	 enzyme	 found	 in	
mitochondria	that	converts	superoxide	into	hydrogen	peroxide.	This	project	focuses	on	
mice	 that	 overexpress	 SOD2.	 Microarray	 analysis	 of	 gene	 expression	 in	 these	 mice	
showed	potentially	defective	OXPHOS	gene	expression.	Preliminary	studies	confirmed	













	 Free	 radicals	 are	 generated	 in	 mitochondria	 as	 a	 byproduct	 of	 oxidative	
phosphorylation	 and	 can	 be	 damaging	 to	 the	 cell.	 Oxidative	 damage	 can	 have	major	
health	 consequences,	 and	 can	 contribute	 to	 various	 diseases	 such	 as	 cancer,	 aging,	
diabetes,	and	Alzheimer’s	disease.3-6	The	health	benefits	of	antioxidants,	which	eliminate	
reactive	oxygen	species,	are	well	recognized	but	are	mechanistically	not	well	understood.	
This	 project	 focuses	 on	 investigating	 the	 physiological	 consequences	 of	 targeted	
antioxidants.	A	preliminary	microarray	was	conducted	using	RNA	isolated	from	livers	of	
mice	 that	 overexpress	 the	 mitochondrial	 antioxidant	 enzyme	 superoxide	 dismutase.	
Although	it	was	expected	that	increased	detoxification	of	superoxide	would	be	beneficial	
to	 oxidative	 phosphorylation,	 gene	 expression	 analysis	 actually	 showed	 potential	
defects.	Since	reactive	oxygen	species	are	known	to	participate	as	signaling	molecules	in	
a	number	of	pathways,	it	is	possible	that	high	levels	of	antioxidants	could	be	detrimental.	
This	 study	 has	 important	 implications	 for	 antioxidant	 therapeutics,	 specifically	when	
used	to	treat	diseases	characterized	by	impaired	liver	function.	
Mitochondria	and	Oxidative	Phosphorylation	




from	NADH	 and	 FADH2	 through	 four	 electron	 transport	 complexes	 and	 ultimately	 to	
	 4	
molecular	 oxygen	 to	 form	










electrons	 flow,	 complexes	 I,	 III,	 and	 IV	 pump	protons	 across	 the	 inner	mitochondrial	
membrane	into	the	intermembrane	space	(Figure	1).	The	proton	gradient	generated	in	
the	 intermembrane	 space	 provides	 chemiosmotic	 energy	 to	 drive	 ATP	 production	 as	
protons	 move	 back	 across	 the	 membrane	 through	 ATP	 synthase	 (complex	 V;	 17	
proteins).	 All	 OXPHOS	 complexes,	 with	 the	 exception	 of	 complex	 II,	 contain	 critical	
proteins	that	are	encoded	in	mitochondrial	DNA.		
Mitochondrial	DNA	
	 	Mitochondria	 are	 specialized	 organelles	 that	 have	 their	 own	 genome.		








prematurely	 transferred	 to	 oxygen	 to	 form	 the	
superoxide	 radical,	 O2·-.	 Proton-coupled	 electron	
transfer	generates	a	proton	gradient	that	drives	ATP	





OXPHOS	 complexes.	 mtDNA	 is	
replicated,	transcribed,	and	translated	
within	the	organelle,	and	all	enzymes	
responsible	 for	 these	 processes	 are	
encoded	 in	 nuclear	 DNA.11	
Mitochondria	 and	 prokaryotes	 have	
many	 similarities,	 and	 it	 is	 thought	




13	 of	 which	 are	 encoded	 in	 mtDNA	
(Figure	 2)	 and	 77	 of	 which	 are	 encoded	 in	 nuclear	 DNA.	 Complex	 I	 contains	 7	
mitochondrial	 subunits	 (ND1,	 ND2,	 ND3,	 ND4L,	 ND4,	 ND5	 and	ND6)	 and	 38	 nuclear	
subunits.	In	complex	III,	1	of	the	11	proteins	(Cyt	b)	is	encoded	by	mtDNA.	Complex	IV	
contains	3	mitochondria-encoded	 subunits	 (COI,	COII,	 and	COIII)	 of	 13	 total,	 and	ATP	
synthase	has	2	of	its	17	proteins	(ATPase6	and	ATPase8)	encoded	in	mtDNA.	Proteins	that	
compose	 complex	 II	 are	 all	 encoded	 by	 nuclear	 DNA.	 Since	 functional	 oxidative	
phosphorylation	 requires	 assembly	 of	 protein	 subunits	 from	 both	 the	 nuclear	 and	
mitochondrial	 genomes,	 close	 coordination	 of	 gene	 expression	 must	 be	 maintained	
between	the	mitochondria	and	the	nucleus.	
	
Figure	 2.	 The	 mitochondrial	 genome.	
mtDNA	 encodes	 13	 proteins	 involved	 in	
OXPHOS.	 NADH	 dehydrogenase	 (ND),	
ubiquinone	 cytochrome	 c	 oxidoreductase	
(Cyt	b),	cytochrome	c	oxidase	(CO),	and	ATP	







reactive	 oxygen	 species	 (ROS),	 specifically	 superoxide.	 Superoxide	 is	 a	 radical	 that	
contains	 a	 single	 unpaired	 electron	 and	 is	 converted	 in	 mitochondria	 to	 hydrogen	
peroxide	 (H2O2)	 by	 manganese	 superoxide	 dismutase	 (SOD2).	 Hydrogen	 peroxide	 is	
membrane	permeable	and	can	leave	the	mitochondria,	be	reduced	to	water	by	catalase,	
or	be	reduced	to	the	reactive	hydroxyl	radical	(OH•)	by	the	Fenton	reaction	with	iron	or	







DNA	 can	 impair	 OXPHOS,	 leading	 to	 more	 ROS	 production	 and	 a	 vicious	 cycle	 that	
provides	the	basis	for	the	free	radical	theory	of	aging.15	ROS	also	contribute	to	various	
degenerative	diseases	and	cancers.16	Cells	protect	themselves	against	free	radicals	using	
antioxidant	 enzymes	 such	 as	 thioredoxin,	 glutathione	 peroxidase,	 peroxiredoxin,	
superoxide	dismutases	,	and	catalase.17		
As	previously	mentioned,	SOD2	is	the	focus	of	this	project.	SOD2	is	an	antioxidant	enzyme	




2O2•-	+	2H+	à	H2O2	+	O2	 	 	 (Equation	1)	
SOD2	reduces	Mn3+	to	Mn2+	and	oxidizes	superoxide	to	oxygen,	then	oxidizes	Mn2+	back	
to	 Mn3+	 to	 reduce	 superoxide	 to	 hydrogen	 peroxide.	 In	 this	 way,	 one	 molecule	 of	
superoxide	is	reduced	and	the	other	is	oxidized.18	
	Mice	 that	 overexpress	 SOD2	
have	 been	 developed	 and	
characterized20	and	are	used	in	
this	 project	 to	 identify	 genes	
responsive	 to	 mitochondrial	
ROS.	These	mice	have	 reduced	
superoxide	 in	 mitochondria	 in	
various	 tissues	 including	 the	
liver,	but	the	levels	of	hydrogen	peroxide	in	these	mice	have	not	been	determined	(Figure	
4).	Although	SOD2	is	not	the	only	enzyme	that	detoxifies	superoxide,	it	is	the	only	one	
that	does	so	 in	 the	mitochondrial	matrix,	where	 the	majority	of	cellular	superoxide	 is	
produced.	Copper/zinc	SOD	(SOD1)	is	a	homodimer	found	in	the	cytosol,	and	also	exists	





overexpressing	 SOD2	 have	 reduced	 superoxide	
levels.	 (A)	 SOD2	 reduces	 superoxide	 to	 hydrogen	
peroxide	which	can	be	broken	down	into	water	and	





the	 four	 complexes	 in	 the	 electron	 transport	 chain	
(Figure	 1).	 It	 is	 found	 in	 the	 mitochondrial	 inner	
membrane,	 and	 is	 responsible	 for	 oxidizing	
nicotinamide	adenine	dinucleotide	hydride	(NADH)	to	
NAD+	 and	 transferring	 two	 electrons	 to	 ubiquinone	



















complex	 I	 to	 ubiquinone,	
then	 to	 DCIP	 to	 form	
DCIPH2.	
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	 Succinate	 dehydrogenase	 (complex	 II)	 is	 the	
second	complex	in	the	electron	transport	chain	and	is	
responsible	 for	oxidizing	 succinate	 to	 fumarate.	The	
oxidation	of	succinate	is	coupled	with	the	reduction	of	
a	prosthetic	group	flavin	adenine	dinucleotide	(FAD)	
to	 the	 dihydrate	 form	 FADH2.23	 Electrons	 within	






	 Ubiquinone-cytochrome	c	oxidoreductase	 (Complex	 III)	 is	 the	 third	complex	 in	
the	 electron	 transport	 chain,	 and	 is	 responsible	 for	 reducing	 two	 molecules	 of	
cytochrome	c.	Cytochrome	c	is	a	one-electron	
carrier	 that	 is	 not	 membrane	 bound.24	 The	
reduction	 of	 cytochrome	 c	 is	 coupled	 to	
oxidation	 of	 ubiquinol	 generated	 by	
complexes	 I	 and	 II	 (Figure	 7).	 Since	
cytochrome	 c	 is	 a	 one-electron	 carrier,	
electrons	from	ubiquinol	must	be	transferred	
one	at	a	time.	The	transfer	of	a	single	electron	
generates	 a	 ubiquinone	 radical,	 which	 is	
	
Figure	 7.	 Ubiquinone-cytochrome	 c	
oxidoreductase	 (complex	 III).	
Electrons	 enter	 complex	 III	 as	
ubiquinol	 and	 are	 used	 to	 reduce	
cytochrome	 c.	 Transfer	 of	 electrons	







complex	 II	 to	 reduce	
ubiquinone	to	ubiquinol.		
	 10	
subsequently	 reduced	during	 a	 second	 cycle	 of	 single	 electron	 transfer.	However,	 the	
ubiquinone	 radical	 can	 donate	 its	 single	 electron	 to	 oxygen	 to	 produce	 a	 superoxide	
radical,	 which	 explains	 how	 complex	 III	 contributes	 to	 the	 generation	 of	 ROS.25	
Therefore,	both	ubiquinol	molecules	from	complexes	I	and	II	enter	complex	III,	and	two	
cytochrome	 c	molecules	 are	 reduced.25	 Four	 hydrogens	 are	 again	 pumped	 out	 of	 the	
mitochondrial	 matrix	 from	 Complex	 III	 into	 the	
intermembrane	 space	 to	 contribute	 to	 the	 proton	
gradient.	 antimycin	 A,	 an	 inhibitor	 of	 complex	 III,	
prevents	ubiquinone	from	binding	to	cytochrome	b.26	
	 Cytochrome	 c	 oxidase	 (Complex	 IV)	 is	
responsible	 for	 oxidizing	 cytochrome	 c	 and	 reducing	
molecular	 oxygen	 to	 water	 (Figure	 8).	 It	 is	 the	 last	
complex	 in	 the	electron	 transport	 chain.	 Four	 reduced	
cytochrome	 c	 molecules	 are	 necessary	 to	 reduce	 one	
molecule	 of	 molecular	 oxygen	 to	 water.27	 Complex	 IV	
contributes	four	protons	to	the	proton	gradient.		
ATP	synthase	(Complex	V)	is	the	final	complex	in	
oxidative	 phosphorylation	 and	 is	 responsible	 for	 the	
generation	 of	 ATP.	 The	 build-up	 of	 protons	 in	 the	
intermembrane	space	provides	energy	in	the	form	of	the	










Figure	 9.	 ATP	 synthase	
(complex	 V).	 The	 proton	
gradient	 generated	 in	 the	
intermembrane	 space	





















functions	 in	 the	 citric	 acid	 cycle.	 Since	 reductions	 in	 complex	 II	 were	 observed,	 it	 is	
possible	 that	 the	 citric	 acid	 cycle	 is	 also	affected	by	SOD2	expression.	Aconitase	 is	 an	
enzyme	that	converts	citrate	to	isocitrate	(Figure	11).	Aconitase	is	especially	sensitive	to	
ROS,	 since	 it	 contains	 a	 functionally	 important	 iron-sulfur	 center	 that	 is	 prone	 to	
	
Figure	 10.	 Representation	 of	 oxidative	
phosphorylation,	 ATP	 synthesis,	 and	
transporters.	 This	 figure	 shows	
complexes	I-V,	as	well	as	the	transporters	
voltage-dependent	anion	channel	(VDAC),	
adenine	 nucleotide	 translocator	 (ANT),	
monocarboxylate	 transporter	 (MT),	 and	








and	 reduces	 NAD(P)+	 to	
NAD(P)H.	 	 Aconitase	 activity	




livers	 to	 determine	 superoxide-
dependent	 gene	 expression	
changes.	 Two	wild-type	 and	 two	
SOD2	 mice	 were	 analyzed.	
Although	 ~1,000	 hepatic	 genes	
were	 differentially	 expressed	 in	
SOD2	mice	compared	to	wild-type	
mice,	 a	 focus	 was	 placed	 on	
mitochondrial	 proteins	 for	 this	
project.	 Specifically,	 analysis	 of	
OXPHOS	gene	expression	showed	
a	 decrease	 in	 nuclear	 encoded	
OXPHOS	subunits	and	an	increase	
		 	
Figure	 12.	 Summary	 of	 preliminary	 microarray	
data.	 Gene	 expression	 analysis	 of	 SOD2	 mice	
showed	 a	 decrease	 in	 21	 nuclear-encoded	
OXPHOS	 subunits	 and	 an	 increase	 in	 5	 of	 the	
mitochondrial	 encoded	 genes	 as	 compared	 to	
wild-type	mice.	
	
Figure	 11.	 Reaction	 scheme	 of	 aconitase	 and	
isocitrate	 dehydrogenase.	 Aconitase	 converts	 citrate	
into	 isocitrate.	 Isocitrate	 dehydrogenase	 oxidizes	




(27.3%)	were	downregulated	 in	 the	SOD2	mice	 (Figure	5)	and	6	of	13	mitochondria-
encoded	subunits	(46.2%)	were	upregulated.	This	indicates	a	failure	in	mitochondria	to	
nucleus	 communication,	 because	 generally	 an	 increase	 in	 mitochondria-encoded	
subunits	 correlates	with	 an	 increase	 in	nuclear-encoded	 subunits	 to	 retain	 functional	
complexes.		
To	 verify	 microarray	 gene	 expression	 changes	 in	 OXPHOS	 complexes,	 sodium	





PAGE.	 The	 Western	 blot	 from	 the	 SDS-PAGE	 gel	 showed	 a	 significant	 reduction	 in	
individual	 protein	 levels	 from	 complexes	 II	 and	 III,	 but	 no	 significant	 change	 was	
observed	in	protein	levels	from	complex	V	(Figure	6A).	The	levels	of	expression	in	SOD2	
increased	 in	 the	 SOD2	 mutant	 mice	 compared	 to	 WT	 as	 expected.	 Although	 the	
expression	of	one	protein	of	the	complex	typically	indicates	a	reduction	in	assembly	of	
the	 entire	 complex,	 it	 is	 important	 to	 analyze	 complex	 assembly	 by	BN-PAGE.	 In	BN-









a	 different	 cohort	 of	 mice,	 as	 well	 as	 to	 investigate	 changes	 in	 other	 complexes.	 In	
addition,	 enzymatic	 activity	 of	 each	 complex	 will	 be	 tested.	 Even	 though	 OXPHOS	
A	 		B	 	
C				 	D	 	

















Arlan	 Richardson	 and	 have	 been	 characterized	 extensively.20	 All	 work	 with	 SOD2	




















































membrane	 was	 activated	 in	 methanol	 for	 one	 minute.	 Following	 activation,	 the	










was	 washed	 in	 1X	 PBS	 for	 5	 minutes	 three	 times.	 The	 blot	 was	 incubated	 with	 the	
appropriate	secondary	antibody	(donkey	anti-mouse	for	all),	at	room	temperature	 for	
one	hour.	Following	incubation,	the	membrane	was	washed	three	times	for	5	minutes	in	













To	summarize,	mouse	 liver	 tissue	(50	mg)	was	homogenized	 in	a	Teflon-glass	Potter-
Elvehjem	homogenizer	and	solubilized	in	0.5	mL	IBc	buffer	[10	mM	Tris-MOPS	(from	0.1	


















I,	 rotenone	was	used	as	an	 inhibitor.	Rotenone	 inhibits	 the	 transfer	of	electrons	 from	













Tris-HCl	 pH	 7.4	 and	 100	 µL	 of	 0.2	 M	 sodium	 succinate	 for	 20	 minutes	 at	 room	
temperature.	Following	preincubation,	10	µL	of	0.2	M	KCN,	10	µL	of	5	mM	DCIP,	and	25	
µL	of	65	mM	phenazine	methosulfate	were	added.	The	reduction	of	DCIP	and	PMS	was	







provided	 in	 the	 kit.	 Concentrations	 and	 components	 of	 buffers	 are	 proprietary.	 The	
reaction	was	initiated	with	50	µL	substrate	solution	provided.	Absorbance	was	measured	
every	minute	 for	30	minutes	at	340	nm.	Each	sample	background	was	measured	and	














	 Western	 blotting	 of	
NDUFS3	 separated	 by	 BN-PAGE	
indicated	no	change	in	complex	I,	
a	 subunit	 of	 complex	 I	 (Figure	
14A).	 Quantitation	 of	 complex	 I	
band	 intensity	normalized	 to	 the	
Coomassie	blue	stained	total	lane	
also	 indicated	 no	 change	 in	
complex	I	between	wild-type	and	
SOD2	 samples	 (Figure	 14B).	 A	
student’s	 unpaired	 t-test	 was	




























Figure	16.	 (A)	Repeat	of	 blue-native	PAGE.	Coomassie	Blue	 staining	 from	 the	gel	
could	not	be	quantitated.	(B)	Quantification	of	pixel	density	of	western	blot	shown	in	





	 Western	blotting	of	 complex	 III	 separated	by	BN	PAGE	 indicated	no	 change	 in	
UQCRC2,	a	subunit	of	complex	III	(Figure	17A).	Quantitation	of	complex	III	band	intensity	
normalized	to	the	Coomassie	blue	stained	total	lane	confirmed	no	change	in	complex	III	




















by	BN	PAGE	 indicated	 a	 decrease	 in	ATP5A,	 a	
subunit	of	complex	V	(Figure	18A).	Quantitation	
of	complex	V	band	 intensity	normalized	to	 the	
Coomassie	 blue	 stained	 total	 protein	 lane	
indicated	a	~60%	decrease	 in	ATP5A	 levels	 in	
the	 SOD2	 samples	 compared	 to	 the	 wild-type	
samples	 (Figure	18B).	 The	 BN-PAGE	 was	
repeated	in	a	different	cohort	of	mice,	the	first	
being	from	liver	samples	brought	from	Yale,	and	
the	 repeat	 from	 tissue	harvested	 from	mice	at	
Appalachian	State	University.	The	results	 from	
the	second	cohort	of	mice	agree	that	there	is	a	
decrease	 in	 complex	 V	 in	 the	 SOD2	 samples	
compared	to	the	wild-type	samples	(Figure	19).	
A		 	B	 	
Figure	19.	 (A)	 Repeated	 Blue-native	 PAGE	western	 blots	 for	 Complex	 V.	 (B)	 Fold	





Figure	 18.	 (A)	 Blue-native	 PAGE	
western	 blots	 for	 Complex	 V.	 (B)	
Fold	 change	 for	 complex	 V	
determined	 by	 quantitating	 pixel	
density	 using	 Image	 J.	 *	 indicates	






An	 NADH	 dehydrogenase	 (complex	 I)	 activity	 assay	 was	 run	 by	 incubating	
mitochondria	with	 NADH	 as	 the	 electron	 donor	 and	 decylubiquinone	 as	 the	 electron	
acceptor.	The	DCIP-coupled	NADH	dehydrogenase	is	characterized	by	a	reduction	in	the	
absorbance	at	600	nm.	DCIP	in	its	reduced	form	has	no	absorbance	at	this	wavelength,	
therefore	 as	 the	 assay	 proceeds,	 there	 is	 a	 colorimetric	 change	 from	 blue	 to	 clear.	
Rotenone,	which	inhibits	complex	I,	was	used	to	determine	complex	I	specificity	of	the	



















in	 a	 change	 in	 slope	 (Figure	 21A,	 C,	 D,	 E).	 Importantly,	 the	 assay	 in	 the	 absence	 of	
decylubiquinone	 still	 showed	 activity,	 indicating	 that	 the	 assay	 is	 decylubiquinone	








































dehydrogenase	 was	 tested	 by	
incubating	 mitochondria	 from	 wild-
type	 samples	 and	 SOD2	 samples	 with	
succinate	 as	 the	 electron	 donor	 and	
decylubiquinone	 as	 the	 electron	
acceptor.	 The	 assay	 shows	 a	 slight	
reduction	in	the	activity	of	complex	II	in	
the	 SOD2	 samples	 compared	 to	 the	
wild-type	 samples	 (Figure	 23).	 This	
change	 in	 activity	 does	 not	 represent	




mitochondria	 in	 each	 sample.	 Figure	
23C	 shows	 the	 activity	 (U/mg)	
normalized	 to	 the	 amount	 of	







Figure	 23.	 Complex	 II	 activity	 assays.	 (A)	
Decrease	in	absorbance	due	to	the	activity	of	




the	 assay.	 In	 Figures	 A	 and	 B,	 the	 same	
volume	was	loaded	into	each	sample,	but	not	
the	same	amount	of	mitochondria.	Once	the	







Because	 complex	 II	 functions	 in	 both	
the	 citric	 acid	 cycle	 and	 OXPHOS,	 aconitase	
activity	was	measured	to	show	whether	there	
was	citric	acid	cycle	dysfunction.	An	aconitase	



































The	 first	 few	 trials	 tested	 activity	 in	 the	 presence	 and	 absence	 of	 rotenone,	 but	 no	
rotenone-sensitivity	 was	 observed	 (Figure	 22A).	 As	 expected,	 mitochondria	 were	
required	to	convert	NADH	to	NAD+.	Since	NADH	is	the	substrate	of	the	reaction,	it	was	
also	not	surprising	that	the	reaction	failed	to	proceed	in	the	absence	of	NADH	(Figure	
22B).	 It	 was	 problematic	 that	 the	 reaction	 proceeded	 in	 the	 absence	 of	 cyanide	 or	
antimycin	A.	Cyanide	 is	an	 inhibitor	of	 complex	 IV,	and	antimycin	A	 is	an	 inhibitor	of	
complex	 III.	 It	 is	 important	 to	 inhibit	 these	 complexes,	 as	 they	 are	 downstream	 of	







The	 activity	 assay	 depends	 on	 the	 transfer	 of	 electrons	 from	 complex	 I	 to	

















complex	 II	 activity	 assay	 showed	 that	 SOD2	mice	 display	 slightly	 reduced	 activity	 of	
succinate	 dehydrogenase;	 however,	 more	 samples	 need	 to	 be	 analyzed	 to	 confirm	
significance	 since	 standard	 deviation	 cannot	 be	 determined.	 Additionally,	 given	 the	
















































mice,	 a	 complete	 metabolic	 analysis	 of	 the	 citric	 acid	 cycle	 pathways	 is	 needed	 to	
determine	 which	 are	 upregulated	 and	 which	 are	 downregulated.	 This	 would	 help	
determine	which	 intermediates	are	 leaving	to	perform	other	 functions,	and	which	are	
inhibited	due	to	the	inhibition	of	succinate	dehydrogenase.			
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